AcquisitionOther
Adamis Pharmaceuticals Corp acquired DMK, including its library of approximately 750 small molecule neuropeptide analogues
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Adamis Pharmaceuticals Corp -> DMK, including its library of approximately 750 small molecule neuropeptide analogues
"Last fall, we initiated a process to explore strategic alternatives for the company with the goal of maximizing stockholder value," stated David J.
Open source record (SEC) ↗